Pure Global

Anti-Inflammatory Effects Of Frequency Specific Microcurrent (FSM) In Osteoarthritic Adults - Trial NCT06390137

Access comprehensive clinical trial information for NCT06390137 through Pure Global AI's free database. This phase not specified trial is sponsored by Nova Southeastern University and is currently Not yet recruiting. The study focuses on Osteoarthritis. Target enrollment is 12 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06390137
Not yet recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT06390137
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Anti-Inflammatory Effects Of Frequency Specific Microcurrent (FSM) In Osteoarthritic Adults
The Immunomodulatory Effects of Frequency Specific Microcurrent In Obese Osteoarthritic Adults

Study Focus

Osteoarthritis

Frequency Specific Microcurrent

Interventional

device

Sponsor & Location

Nova Southeastern University

Timeline & Enrollment

N/A

Apr 01, 2024

May 01, 2024

12 participants

Primary Outcome

Interleukin-6

Summary

It is hypothesized that application of frequency specific microcurrent can decrease
 inflammation in osteoarthritis patients resulting in decreased pain and potentially decrease
 disease progression. Participants will received the microcurrent treatment for one hour and a
 total of five blood draws to measure inflammatory markers. Participants will also complete a
 pre and post treatment pain questionnaire.

ICD-10 Classifications

Other hypertrophic osteoarthropathy
Other specified osteochondropathies
Polyarthritis, unspecified
Other osteochondropathies
Osteochondritis dissecans

Data Source

ClinicalTrials.gov

NCT06390137

Device Trial